Friday 6 November 2026
Export DHR’s income statement to Excel — free account
Danaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024.
- Revenue
- +8.28%
- EPS
- +36.7%
- Free cash flow
- +19.1%
- Total debt
- +44.9%
Quarter to September 2026, against a year earlier
230.20
3.86
+1.71%
Follow DHR
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 6 | 6 |
| 7.08% | 7.11% | 7.63% | 8.27% | ||
| 4.49% | 4.54% | 4.60% | 5.00% | ||
ROIC |
4.42% | 4.59% | 4.37% | 4.51% | |
Return on Tangible Assets |
31.48% | 30.89% | 36.07% | 37.63% | |
Average Days of Receivables |
58.13 | 56.26 | 57.64 | 58.81 | |
Free Cash Flow per Share |
7.43 | 7.51 | 7.78 | 8.17 | |
Free Cash Flow |
5,293.00 | 5,318.00 | 5,489.00 | 5,751.00 | |
Capital Expenditures |
(1,123.00) | (1,121.00) | (1,146.00) | (1,108.00) | |
| Other line items | |||||
Cash ROIC |
7.00% | 6.98% | 6.69% | 6.87% | |
Accounts Receivable Turnover |
6.60 | 6.77 | 6.67 | 6.50 | |
Accounts Payable Turnover |
5.59 | 5.79 | 5.87 | 6.16 | |
Inventory Turnover |
4.17 | 3.96 | 3.50 | 3.65 | |
Average Days of Payables |
67.00 | 64.21 | 63.85 | 59.97 | |
Days of Inventory on Hand |
90.44 | 93.55 | 114.24 | 107.89 | |
Tax Rate |
(0.15) | (0.15) | (0.16) | (0.11) | |
Research and Development Expense of Revenue |
6.50% | 6.48% | 6.43% | 6.52% | |
Selling, General and Administrative Expense of Revenue |
33.52% | 33.24% | 31.66% | 31.70% | |
Share Based Compensation of Revenue |
1.21% | 1.19% | 1.18% | 1.28% | |
Interest Coverage |
17.70 | 18.59 | 17.56 | 14.49 | |
Operating CF/Net income |
1.78 | 1.75 | 1.66 | 1.58 | |
Depreciation/Fixed assets |
0.44 | 0.45 | 0.44 | 0.48 | |
Capex/Depreciation |
(0.46) | (0.45) | (0.44) | (0.40) | |
Revenue per Share |
34.47 | 35.00 | 35.60 | 36.39 | |
Operating CF per Share |
9.00 | 9.10 | 9.41 | 9.75 | |
Capex per Share |
(1.58) | (1.58) | (1.62) | (1.57) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.04 |
Columns are period end dates · fundamentals updated 2 Nov 2026